Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  NASDAQ OMX HELSINKI LTD.  >  Orion Oyj    ORNBV   FI0009014377

ORION OYJ (ORNBV)
Mes dernières consult.
Most popular
Report
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Omx Helsinki Ltd.
12/08/2017 12/11/2017 12/12/2017 12/13/2017 12/14/2017 Date
30.3(c) 29.98(c) 30.81(c) 30.89(c) 30.71 Last
433 867 482 121 574 069 387 386 5 275 Volume
+1.07% -1.06% +2.77% +0.26% -0.58% Change
More quotes
Financials (€)
Sales 2017 1 088 M
EBIT 2017 281 M
Net income 2017 224 M
Finance 2017 71,4 M
Yield 2017 4,60%
Sales 2018 1 141 M
EBIT 2018 305 M
Net income 2018 244 M
Finance 2018 96,6 M
Yield 2018 4,82%
P/E ratio 2017 19,54
P/E ratio 2018 18,03
EV / Sales2017 3,99x
EV / Sales2018 3,79x
Capitalization 4 415 M
More Financials
Company
Orion Oyj engages in the development of pharmaceutical and diagnostic test.It develops, manufactures, and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic tests.Its pharmaceutical research and development focuses on central nervous system drugs,... 
Sector
Pharmaceuticals
Calendar
02/07Earnings Release
More about the company
Surperformance© ratings of Orion Oyj
Trading Rating : Investor Rating :
More Ratings
Latest news on ORION OYJ
11/07 ORION OYJ : Professor Heikki Joensuu has been appointed Vice President of Therap..
11/07 ORION OYJ : Professor Heikki Joensuu has been appointed Vice President of Therap..
11/01 ORION CORPORATION : Managers' transactions - Hilpi Rautelin
10/26 ORION OYJ : Composition of the Nomination Committee of Orion Corporation
10/26 ORION OYJ : Composition of the Nomination Committee of Orion Corporation
10/26 ORION OYJ : Group Interim Report January-September 2017
10/12 ORION OYJ : Publishing of Orion Corporation's Interim Report for January-Septemb..
10/05 ORION OYJ : receives Lean Prize 2016
09/22 ORION OYJ : Pharma scientists led research group wins award for study paper on d..
08/18 ORION CORPORATION : Managers' transactions - Heikki Westerlund
More news
Sector news : Pharmaceuticals - NEC
12/13 TEVA PHARMACEUTICAL INDUSTRIES : Fears of Israeli job cuts at Teva sparks call f..
12/13 France's Sanofi pins hopes on new drugs after setbacks
12/13DJELI LILLY AND : Sees Modest Revenue Growth in 2018
12/13 SANOFI : CEO says M&A targets in oncology are 'very expensive'
12/13DJPLANT IMPACT : Needs Extra GBP7 Million Funding by April, Hands up 'For Sale' Si..
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
05/23 Orion Corporation (ORINF) Investor Presentation - Slideshow
05/23 Orion Corporation (ORINF) Investor Presentation - Slideshow
Chart ORION OYJ
Duration : Period :
Orion Oyj Technical Analysis Chart | ORNBV | FI0009014377 | 4-Traders
Technical analysis trends ORION OYJ
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 9
Average target price 40,3 €
Spread / Average Target 30%
EPS Revisions
Managers
NameTitle
Timo Antero Lappalainen President & Chief Executive Officer
Heikki Seppo Westerlund Chairman
Jari Karlson CFO, SVP-Animal Health & IR Contact
Christer Nordstedt Senior Vice President-Research & Development
Sirpa Tuulikki Jalkanen Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ORION OYJ-28.35%5 220
JOHNSON & JOHNSON21.53%379 175
NOVARTIS12.01%218 773
PFIZER10.04%215 837
ROCHE HOLDING LTD.3.40%209 423
MERCK AND COMPANY-6.96%153 659